We are live on ! Find out more
BPTH

Bio-Path Holdings Inc

Delisted

BPTH was delisted on the 18th of February, 2025.

14 hedge funds and large institutions have $847K invested in Bio-Path Holdings Inc in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

26% less capital invested

Capital invested by funds: $1.14M → $847K (-$292K)

26% less funds holding

Funds holding: 1914 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
14
Holders Change
-5
Holders Change %
-26.32%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
4
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$259K +$77.7K +830 +37%
BlackRock
2
BlackRock
New York
$254K
Vanguard Group
3
Vanguard Group
Pennsylvania
$220K +$72.2K +771 +42%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$87K
UBS Group
5
UBS Group
Switzerland
$10K +$8.14K +87 +256%
Morgan Stanley
6
Morgan Stanley
New York
$9K +$4.96K +53 +104%
HI
7
Human Investing
Oregon
$8K
SM
8
Sabby Management
Florida
-$227K -2,250 Closed
Bank of Montreal
9
Bank of Montreal
Ontario, Canada
-$46.8K -500 -100%
TRCT
10
Tower Research Capital (TRC)
New York
-$14K -135 Closed
PA
11
Procyon Advisors
Connecticut
-$13K -125 Closed
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
-$655 -7 Closed

BPTH Hedge Fund Activity: Q3 2020 in Review

14 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q3 2020, worth a combined $847K — down 26% from $1.14M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of BPTH and 0 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $77.7K. The largest seller was Sabby Management, exiting entirely with an estimated $227K sold.

  • 14 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q3 2020, down from 19 in Q2 2020.
  • Funds reported $847K of Bio-Path Holdings Inc stock for Q3 2020, down 26% quarter-over-quarter.
  • 0 funds opened new Bio-Path Holdings Inc positions in Q3 2020 and 5 closed out, a net change of -5 holders.
  • The largest Bio-Path Holdings Inc buyer in Q3 2020 was Renaissance Technologies, an estimated $77.7K added.
  • The largest Bio-Path Holdings Inc seller in Q3 2020 was Sabby Management, an estimated $227K sold.

Based on aggregated 13F filings for Q3 2020.